Preferred Label : pegloticase;

MeSH note : uricase covalently attached to polyethylene glycol, modifying 71% of amino groups & retaining 11% of activity without eliciting antibody response in mice or man; used for lowering serum uric acid;

CISMeF synonym : krystexxa; mountain view pharmaceuticals brand of pegloticase; puricase; savient pharmaceuticals brand of pegloticase;

MeSH synonym : PEG-uricase; polyethylene glycol-uricase; methoxypolyethylene glycol uricase;

Is substance : O;

UNII : R581OT55EA;

Details


Main resources

You can consult :


This medicine is now withdrawn from use in the European Union
https://www.ema.europa.eu/medicines/human/EPAR/Krystexxa
2013
false
United Kingdom
English
French
Pegloticase 8mg/mL solution for intravenous infusion (product)
drug approval
treatment outcome
pegloticase
pegloticase
pegloticase
infusions, intravenous
adult
chronic disease
chronic tophaceous gout
gout
package leaflet
summary of product characteristics
drug evaluation
syndication feed
pregnancy
breast feeding
clinical trials, phase iii as topic
drug evaluation, preclinical
polyethylene glycols
polyethylene glycols
urate oxidase
urate oxidase

---
http://www.cochrane.org/fr/CD008335
2010
United Kingdom
France
French
review of literature
gout
chronic disease
polyethylene glycols
urate oxidase
pegloticase
treatment outcome
french abstract

---
Nous contacter.
01/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.